These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7570993)
1. Delayed renal allograft function. Importance of the dialysis membrane. Pascual M; Tolkoff-Rubin N Transplantation; 1995 Oct; 60(7):769. PubMed ID: 7570993 [No Abstract] [Full Text] [Related]
2. Biocompatibility of dialysis membranes. Salem M; Ivanovich P; Mujais S Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063 [No Abstract] [Full Text] [Related]
3. The 'first-use syndrome' revisited: a dialysis centre's perspective. Ing TS; Wong FK; Cheng YL; Potempa LD Nephrol Dial Transplant; 1995; 10 Suppl 10():39-44. PubMed ID: 8825431 [No Abstract] [Full Text] [Related]
4. The role of dialysis membranes in infection. Vanholder R; Van Loo A; Dhondt AM; Ringoir S Nephrol Dial Transplant; 1996; 11 Suppl 2():101-3. PubMed ID: 8804006 [No Abstract] [Full Text] [Related]
5. Quantitation of membrane biocompatibility. Colton CK Contrib Nephrol; 1987; 59():110-25. PubMed ID: 3502085 [No Abstract] [Full Text] [Related]
6. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure. Himmelfarb J; Hakim RM J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611 [No Abstract] [Full Text] [Related]
7. Clinical importance of biocompatibility and its effect on haemodialysis treatment. Opatrný K Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v41-4. PubMed ID: 12817068 [No Abstract] [Full Text] [Related]
9. Biocompatibility: is it a relevant consideration for today's haemodialysis? Shaldon S; Vienken J Int J Artif Organs; 1996 Apr; 19(4):201-14. PubMed ID: 8786170 [No Abstract] [Full Text] [Related]
10. AN69-ST membrane, a useful option in two cases of severe dialysis reactions. Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312 [TBL] [Abstract][Full Text] [Related]
11. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes? Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897 [No Abstract] [Full Text] [Related]
12. In vivo evaluation of cellular and inflammatory response to a new polyethersulfone membrane. Stefoni S; Coli L; Cianciolo G; Donati G; Dalmastri V; Orlandi V; D'Addio F; Ramazzotti E Contrib Nephrol; 2003; (138):68-79. PubMed ID: 12463148 [No Abstract] [Full Text] [Related]
13. Clinical sequelae of complement activation in hemodialysis. Hakim RM Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474 [TBL] [Abstract][Full Text] [Related]
14. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility? Ward RA Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427 [No Abstract] [Full Text] [Related]
15. [Biocompatibility of membranes: long-term effects]. Man NK Rev Prat; 1990 Feb; 40(5):458-63. PubMed ID: 2309075 [No Abstract] [Full Text] [Related]
16. Role of bioincompatibility in dialysis morbidity and mortality. Lazarus JM; Owen WF Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663 [TBL] [Abstract][Full Text] [Related]